iScience (Jul 2023)

Activating FcγR function depends on endosomal-signaling platforms

  • Samira Benadda,
  • Mathilde Nugue,
  • Despoina Koumantou,
  • Marcelle Bens,
  • Mariacristina De Luca,
  • Olivier Pellé,
  • Renato C. Monteiro,
  • Irini Evnouchidou,
  • Loredana Saveanu

Journal volume & issue
Vol. 26, no. 7
p. 107055

Abstract

Read online

Summary: Cell surface receptor internalization can either terminate signaling or activate alternative endosomal signaling pathways. We investigated here whether endosomal signaling is involved in the function of the human receptors for Fc immunoglobulin fragments (FcRs): FcαRI, FcγRIIA, and FcγRI. All these receptors were internalized after their cross-linking with receptor-specific antibodies, but their intracellular trafficking was different. FcαRI was targeted directly to lysosomes, while FcγRIIA and FcγRI were internalized in particular endosomal compartments described by the insulin responsive aminopeptidase (IRAP), where they recruited signaling molecules, such as the active form of the kinase Syk, PLCγ and the adaptor LAT. Destabilization of FcγR endosomal signaling in the absence of IRAP compromised cytokine secretion downstream FcγR activation and macrophage ability to kill tumor cells by antibody-dependent cell-mediated cytotoxicity (ADCC). Our results indicate that FcγR endosomal signaling is required for the FcγR-driven inflammatory reaction and possibly for the therapeutic action of monoclonal antibodies.

Keywords